{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:23Z","timestamp":1794047483038,"version":"4.8.0"},"reference-count":40,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"2","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>High levels of branched-chain amino acid (BCAA) transaminase 1 (BCAT1) have been associated with tumor aggressiveness and drug resistance in several cancer types. Nevertheless, the mechanistic role of BCAT1 in T-cell acute lymphoblastic leukemia (T-ALL) remains uncertain. We provide evidence that Bcat1 was over-expressed following NOTCH1-induced transformation of leukemic progenitors and that NOTCH1 directly controlled BCAT1 expression by binding to a BCAT1 promoter. Further, using a NOTCH1 gain-of-function retroviral model of T-ALL, mouse cells genetically deficient for Bcat1 showed defects in developing leukemia. In murine T-ALL cells, Bcat1 depletion or inhibition redirected leucine metabolism towards production of 3-hydroxy butyrate (3-HB), an endogenous histone deacetylase inhibitor. Consistently, BCAT1-depleted cells showed altered protein acetylation levels which correlated with a pronounced sensitivity to DNA damaging agents. In human NOTCH1-dependent leukemias, high expression levels of BCAT1 may predispose to worse prognosis. Therapeutically, BCAT1 inhibition specifically synergized with etoposide to eliminate tumors in patient-derived xenograft models suggesting that BCAT1 inhibitors may have a part to play in salvage protocols for refractory T-ALL.<\/jats:p>","DOI":"10.3324\/haematol.2024.285552","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T15:41:37Z","timestamp":1725550897000},"page":"350-367","source":"Crossref","is-referenced-by-count":7,"title":["BCAT1 is a NOTCH1 target and sustains the oncogenic function of NOTCH1"],"prefix":"10.3324","volume":"110","author":[{"given":"Valeria","family":"Tosello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Di Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adonia E.","family":"Papathanassiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Dalla","family":"Santa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Mussolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Van Vlierberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Piovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"71908","doi-asserted-by":"crossref","unstructured":"Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017; 7(6):e577.","DOI":"10.1038\/bcj.2017.53"},{"key":"71909","doi-asserted-by":"crossref","unstructured":"Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008; 371(9617):1030-1043.","DOI":"10.1016\/S0140-6736(08)60457-2"},{"key":"71910","doi-asserted-by":"crossref","unstructured":"Belver L, Ferrando A. The genetics and mechanisms of T cell acute lymphoblastic leukaemia. Nature reviews Cancer. 2016; 16(8):494-507.","DOI":"10.1038\/nrc.2016.63"},{"key":"71911","doi-asserted-by":"crossref","unstructured":"Bongiovanni D, Saccomani V, Piovan E. Aberrant signaling pathways in T-cell acute lymphoblastic leukemia. Int J Mol Sci. 2017; 18(9):1904.","DOI":"10.3390\/ijms18091904"},{"key":"71912","doi-asserted-by":"crossref","unstructured":"Weng AP, Ferrando AA, Lee W. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004; 306(5694):269-271.","DOI":"10.1126\/science.1102160"},{"key":"71913","doi-asserted-by":"crossref","unstructured":"Ferrando AA. The role of NOTCH1 signaling in T-ALL. Hematology Am Soc Hematol Educ Program. 2009;353-361.","DOI":"10.1182\/asheducation-2009.1.353"},{"key":"71914","doi-asserted-by":"crossref","unstructured":"Palomero T, Lim WK, Odom DT. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci U S A. 2006; 103(48):18261-18266.","DOI":"10.1073\/pnas.0606108103"},{"key":"71915","doi-asserted-by":"crossref","unstructured":"Weng AP, Millholland JM, Yashiro-Ohtani Y. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia\/lymphoma. Genes Dev. 2006; 20(15):2096-2109.","DOI":"10.1101\/gad.1450406"},{"key":"71916","doi-asserted-by":"crossref","unstructured":"Vermezovic J, Adamowicz M, Santarpia L. Notch is a direct negative regulator of the DNA-damage response. Nat Struct Mol Biol. 2015; 22(5):417-424.","DOI":"10.1038\/nsmb.3013"},{"key":"71917","doi-asserted-by":"crossref","unstructured":"Di Veroli GY, Fornari C, Wang D. Combenefit: an interactive platform for the analysis and visualization of drug combinations. Bioinformatics. 2016; 32(18):2866-2868.","DOI":"10.1093\/bioinformatics\/btw230"},{"key":"71918","doi-asserted-by":"crossref","unstructured":"Li X, Gounari F, Protopopov A, Khazaie K, von Boehmer H. Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1. J Exp Med. 2008; 205(12):2851-2861.","DOI":"10.1084\/jem.20081561"},{"key":"71919","doi-asserted-by":"crossref","unstructured":"Sanda T, Li X, Gutierrez A. Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia. Blood. 2010; 115(9):1735-1745.","DOI":"10.1182\/blood-2009-07-235143"},{"key":"71920","doi-asserted-by":"crossref","unstructured":"Ng OH, Erbilgin Y, Firtina S. Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia. Blood Cancer J. 2014; 4(3):e192.","DOI":"10.1038\/bcj.2014.12"},{"key":"71921","doi-asserted-by":"crossref","unstructured":"Van Vlierberghe P, Ambesi-Impiombato A, Perez-Garcia A. ETV6 mutations in early immature human T cell leukemias. J Exp Med. 2011; 208(13):2571-2579.","DOI":"10.1084\/jem.20112239"},{"key":"71922","doi-asserted-by":"crossref","unstructured":"Thandapani P, Kloetgen A, Witkowski MT. Valine tRNA levels and availability regulate complex I assembly in leukaemia. Nature. 2022; 601(7893):428-433.","DOI":"10.1038\/s41586-021-04244-1"},{"key":"71923","doi-asserted-by":"crossref","unstructured":"Liu Y, Easton J, Shao Y. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet. 2017; 49(8):1211-1218.","DOI":"10.1038\/ng.3909"},{"key":"71924","doi-asserted-by":"crossref","unstructured":"Gutierrez A, Sanda T, Grebliunaite R. High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. Blood. 2009; 114(3):647-650.","DOI":"10.1182\/blood-2009-02-206722"},{"key":"71925","doi-asserted-by":"crossref","unstructured":"Chen B, Jiang L, Zhong ML. Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2018; 115(2):373-378.","DOI":"10.1073\/pnas.1717125115"},{"key":"71926","doi-asserted-by":"crossref","unstructured":"Agnusdei V, Minuzzo S, Frasson C. Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts. Leukemia. 2014; 28(2):278-288.","DOI":"10.1038\/leu.2013.183"},{"key":"71927","doi-asserted-by":"crossref","unstructured":"Bordin F, Piovan E, Masiero E. WT1 loss attenuates the TP53-induced DNA damage response in T-cell acute lymphoblastic leukemia. Haematologica. 2018; 103(2):266-277.","DOI":"10.3324\/haematol.2017.170431"},{"key":"71928","doi-asserted-by":"crossref","unstructured":"Saccomani V, Grassi A, Piovan E. miR-22-3p negatively affects tumor progression in T-cell acute lymphoblastic leukemia. Cells. 2020; 9(7):1726.","DOI":"10.3390\/cells9071726"},{"key":"71929","doi-asserted-by":"crossref","unstructured":"Ngondo-Mbongo RP, Myslinski E, Aster JC, Carbon P. Modulation of gene expression via overlapping binding sites exerted by ZNF143, Notch1 and THAP11. Nucleic Acids Res. 2013; 41(7):4000-4014.","DOI":"10.1093\/nar\/gkt088"},{"key":"71930","doi-asserted-by":"crossref","unstructured":"Lehal R, Zaric J, Vigolo M. Pharmacological disruption of the Notch transcription factor complex. Proc Natl Acad Sci U S A. 2020; 117(28):16292-16301.","DOI":"10.1073\/pnas.1922606117"},{"key":"71931","doi-asserted-by":"crossref","unstructured":"Winter GE, Mayer A, Buckley DL. BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment. Mol Cell. 2017; 67(1):5-18.","DOI":"10.1016\/j.molcel.2017.06.004"},{"key":"71932","unstructured":"Lodi F, Certo M, Elkafrawy H. BCAT1 inhibition affects CD8+ T cell activation, exhaustion, and tumoral immunity by altering iron homeostasis. bioRxiv. 2023."},{"key":"71933","doi-asserted-by":"crossref","unstructured":"Ko JH, Olona A, Papathanassiu AE. BCAT1 affects mitochondrial metabolism independently of leucine transamination in activated human macrophages. J Cell Sci. 2020; 133(22)","DOI":"10.1242\/jcs.247957"},{"key":"71934","doi-asserted-by":"crossref","unstructured":"Shimazu T, Hirschey MD, Newman J. Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 2013; 339(6116):211-214.","DOI":"10.1126\/science.1227166"},{"key":"71935","doi-asserted-by":"crossref","unstructured":"Francois L, Boskovic P, Knerr J. BCAT1 redox function maintains mitotic fidelity. Cell Rep. 2022; 41(3):111524.","DOI":"10.1016\/j.celrep.2022.111524"},{"key":"71936","doi-asserted-by":"crossref","unstructured":"Fabbri G, Rasi S, Rossi D. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med. 2011; 208(7):1389-1401.","DOI":"10.1084\/jem.20110921"},{"key":"71937","doi-asserted-by":"crossref","unstructured":"Fabbri G, Holmes AB, Viganotti M. Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2017; 114(14):E2911-E2919.","DOI":"10.1073\/pnas.1702564114"},{"key":"71938","doi-asserted-by":"crossref","unstructured":"Herold T, Jurinovic V, Metzeler KH. An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia. Leukemia. 2011; 25(10):1639-1645.","DOI":"10.1038\/leu.2011.125"},{"key":"71939","doi-asserted-by":"crossref","unstructured":"Ananieva EA, Powell JD, Hutson SM. Leucine metabolism in T cell activation: mTOR signaling and beyond. Adv Nutr. 2016; 7(4):798S-805S.","DOI":"10.3945\/an.115.011221"},{"key":"71940","doi-asserted-by":"crossref","unstructured":"Hillier J, Allcott GJ, Guest LA. The BCAT1 CXXC motif provides protection against ROS in acute myeloid leukaemia cells. Antioxidants (Basel). 2022; 11(4):683.","DOI":"10.3390\/antiox11040683"},{"key":"71941","doi-asserted-by":"crossref","unstructured":"Harris M, El Hindy M, Usmari-Moraes M. BCAT-induced autophagy regulates Abeta load through an interdependence of redox state and PKC phosphorylation-implications in Alzheimer\u2019s disease. Free Radic Biol Med. 2020; 152:755-766.","DOI":"10.1016\/j.freeradbiomed.2020.01.019"},{"key":"71942","doi-asserted-by":"crossref","unstructured":"Rodrigues LM, Uribe-Lewis S, Madhu B, Honess DJ, Stubbs M, Griffiths JR. The action of beta-hydroxybutyrate on the growth, metabolism and global histone H3 acetylation of spontaneous mouse mammary tumours: evidence of a beta-hydroxybutyrate paradox. Cancer Metab. 2017; 5:4.","DOI":"10.1186\/s40170-017-0166-z"},{"key":"71943","doi-asserted-by":"crossref","unstructured":"Rojas-Morales P, Pedraza-Chaverri J, Tapia E. Ketone bodies, stress response, and redox homeostasis. Redox Biol. 2020; 29:101395.","DOI":"10.1016\/j.redox.2019.101395"},{"key":"71944","doi-asserted-by":"crossref","unstructured":"Ananieva EA, Wilkinson AC. Branched-chain amino acid metabolism in cancer. Curr Opin Clin Nutr Metab Care. 2018; 21(1):64-70.","DOI":"10.1097\/MCO.0000000000000430"},{"key":"71945","doi-asserted-by":"crossref","unstructured":"Luo L, Sun W, Zhu W. BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism. Cell Death Dis. 2021; 12(2):169.","DOI":"10.1038\/s41419-021-03456-7"},{"key":"71946","doi-asserted-by":"crossref","unstructured":"Chen CS, Wang YC, Yang HC. Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation. Cancer Res. 2007; 67(11):5318-5327.","DOI":"10.1158\/0008-5472.CAN-06-3996"},{"key":"71947","doi-asserted-by":"crossref","unstructured":"Hada M, Kwok RP. Regulation of ku70-bax complex in cells. J Cell Death. 2014; 7:11-13.","DOI":"10.4137\/JCD.S13695"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.285552\/77487","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.285552\/78030","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11745\/77487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:07:16Z","timestamp":1794046036000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2024.285552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2024.285552","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,5]]}}}